Gregory K. Hayer,Brendan Magrab,Henry R. Wolfe, Jr.
申请号：
US15710306
公开号：
US10471115B2
申请日:
2017.09.20
申请国别(地区):
US
年份:
2019
代理人:
摘要：
An oral dosage form or plurality of oral dosage forms comprising as active ingredients combinations of citric acid, magnesium citrate, phytin, pyridoxine, and musa is disclosed. The oral dosage form(s) is useful for inhibiting calcium oxalate crystal growth and for treating or inhibiting growth of kidney stones. Methods of inhibiting calcium oxalate crystal growth and of treating or preventing kidney stones are also disclosed.
